- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
PD-1 is a central placed co-stimulatory factor that plays an important role in keeping our immunological tolerance.
2015.06.11 | Mads Henning Jensen
| Date | Wed 23 Sep |
| Time | 11:00 — 14:00 |
| Location | TBA |
Recently anti-PD-1 and anti-PD-L1 antibodies have shown to be extremely potent treatments for various cancers.
MSD Denmark and Merck Research labs, Palo Alto, will host a seminar on the PD-1 axis.
The talks will be given by Elaine Pinheiro, from Merck Research labs, Boston and Jennifer H. Yearley, both from Merck Research labs, Palo Alto. They have both played a central role in the development of anti-PD-1 treatment for Merck/MSD.
Sandwiches will be provided by MSD Denmark during the seminar.
A detailed program will follow.